Lifecome Biochemistry Co.,Ltd.

XSEC:002868 Stock Report

Market Cap: CN¥2.4b

Lifecome BiochemistryLtd Management

Management criteria checks 3/4

Lifecome BiochemistryLtd's CEO is Tanping Lai, appointed in Dec 2009, has a tenure of 15.08 years. directly owns 1% of the company’s shares, worth CN¥23.85M. The average tenure of the management team and the board of directors is 9 years and 6.7 years respectively.

Key information

Tanping Lai

Chief executive officer

CN¥462.5k

Total compensation

CEO salary percentagen/a
CEO tenure15.1yrs
CEO ownership1.0%
Management average tenure9yrs
Board average tenure6.7yrs

Recent management updates

Recent updates


CEO

Tanping Lai (60 yo)

15.1yrs

Tenure

CN¥462,500

Compensation

Mr. Tanping Lai is General Manager & Chairman of the Board of Lifecome Biochemistry Co.,Ltd. from December 2009 and served as its Acting Secretary until April 27, 2023.


Leadership Team

NamePositionTenureCompensationOwnership
Tanping Lai
Chairman of the Board & GM15.1yrsCN¥462.50k1%
CN¥ 23.9m
Zhongshou Bao
Financial Director12.7yrsCN¥242.30k0.070%
CN¥ 1.7m
Junhui Li
Deputy GM & Technical Director7.7yrsCN¥241.80k0.081%
CN¥ 1.9m
Jing Yang
Deputy GM & Director3.8yrsCN¥425.40kno data
Hui Huang
Deputy General Manager9yrsCN¥431.10k0.13%
CN¥ 3.2m

9.0yrs

Average Tenure

47yo

Average Age

Experienced Management: 002868's management team is seasoned and experienced (9 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Tanping Lai
Chairman of the Board & GM15.1yrsCN¥462.50k1%
CN¥ 23.9m
Jing Yang
Deputy GM & Director2.3yrsCN¥425.40kno data
Zhenwu Feng
Supervisory Board Chairman18.7yrsno data0.074%
CN¥ 1.8m
Lijun Lou
Shareholder Representative Supervisor12.7yrsno data0.032%
CN¥ 770.2k
Jiumin Lai
Non-Independent Director3.8yrsCN¥86.60kno data
Qing Tan
Independent Director6.7yrsCN¥86.60kno data
Xinren Zhang
Independent Director6.7yrsCN¥86.60kno data
Jun Meng
Employee Representative Supervisor3.8yrsno datano data

6.7yrs

Average Tenure

47yo

Average Age

Experienced Board: 002868's board of directors are considered experienced (6.7 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/24 19:55
End of Day Share Price 2025/01/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Lifecome Biochemistry Co.,Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution